| Mar'19 | Mar'18 | Mar'17 | Mar'16 | Mar'15 | Mar'14 | Mar'13 | Mar'12 | Mar'11 |
|---|---|---|---|---|---|---|---|---|
REVENUES | ||||||||
Government contract revenue | ||||||||
- | - | 392 | - | - | - | - | - | - |
Government contract revenue | ||||||||
- | - | - | 886 | 762 | 1,623 | - | 1,358 | - |
Product sales | ||||||||
- | - | - | - | - | - | - | 1 | - |
Government contract revenue | ||||||||
229 | 149 | 392 | 886 | 762 | 1,623 | 1,230 | 1,359 | - |
Total revenues | ||||||||
229 | 149 | 392 | 886 | - | - | 1,230 | 1,359 | - |
OPERATING EXPENSES | ||||||||
Professional fees | ||||||||
2,192 | 1,553 | 2,161 | 2,259 | 1,572 | 1,521 | 1,892 | 1,566 | 1,112 |
Payroll and related expenses | ||||||||
3,083 | 2,634 | 3,479 | 2,083 | 2,275 | 2,227 | 2,166 | 2,054 | 2,902 |
General and administrative | ||||||||
953 | 792 | 849 | 929 | 907 | 931 | 746 | 852 | 542 |
Total operating expenses | ||||||||
6,228 | 4,980 | 6,490 | 5,271 | 4,755 | 4,679 | 4,805 | 4,473 | 4,557 |
OPERATING LOSS | ||||||||
-5,999 | -4,831 | -6,098 | -4,384 | -3,992 | -3,055 | -3,575 | -3,114 | -4,557 |
OTHER (INCOME) EXPENSE | ||||||||
Loss on debt conversion | ||||||||
- | - | - | - | - | -40 | 139 | -77 | - |
Change in fair value of derivative liabilities | ||||||||
- | - | - | - | - | -8,547 | 44 | 766 | 6,079 |
Loss on litigation settlement | ||||||||
- | - | - | - | - | -583 | 0 | - | - |
Other income | ||||||||
- | - | - | - | 219 | 75 | - | - | - |
Interest and other debt expenses | ||||||||
220 | 361 | 304 | 573 | 452 | 1,287 | -1,132 | -3,793 | 3,951 |
Warrant repricing expense | ||||||||
- | - | 345 | 0 | - | - | - | - | - |
(Gain) on share for warrant exchanges | ||||||||
0 | -130 | 0 | - | - | - | - | - | - |
Loss on debt extinguishment | ||||||||
0 | -376 | -558 | 0 | -2,753 | - | - | - | -3,306 |
Total other expense | ||||||||
- | - | - | -573 | - | - | - | - | - |
Interest income | ||||||||
- | - | - | - | - | - | - | 359 | 23 |
Total other expense | ||||||||
220 | 868 | 1,208 | - | 2,986 | 10,383 | 0 | - | - |
Total other (income) expense | ||||||||
- | - | - | - | - | - | 1,316 | 4,997 | -1,154 |
NET LOSS | ||||||||
-6,219 | -5,699 | -7,306 | -4,958 | -6,979 | -13,438 | -4,892 | - | - |
LOSS ATTRIBUTABLE TO NONCONTROLLING INTERESTS | ||||||||
-24 | -20 | -30 | -86 | -182 | -81 | 0 | - | - |
NET LOSS ATTRIBUTABLE TO AETHLON MEDICAL, INC. | ||||||||
-6,194 | -5,679 | -7,276 | -4,872 | -6,797 | -13,357 | -4,892 | -8,111 | -5,711 |
BASIC AND DILUTED LOSS PER COMMON SHARE | ||||||||
-0.07 | -0.10 | -0.94 | -0.66 | -1.22 | -3.44 | -0.03 | -0.08 | -0.08 |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED | ||||||||
18,124 | 12,317 | 7,764 | 7,393 | 5,594 | 3,881 | - | - | 69,610 |
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC AND DILUTED | ||||||||
- | - | - | - | - | - | 149,223 | 101,765 | - |
Government Contract Revenue [Member] | ||||||||
Total revenues | ||||||||
229 | 149 | - | - | - | - | - | - | - |